In contrast to aggressive and fast-growing tumor types, such as lung adenocarcinoma, a previous study demonstrated variations in Prdx5 mRNA levels as prognostic factors in lung cancer, with low levels of Prdx5 correlating with poor overall survival [70]. This evidence concerns the gene PRDX5 and neoplasm.